A detailed history of Ameriprise Financial Inc transactions in Liva Nova PLC stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,054,038 shares of LIVN stock, worth $49.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,054,038
Previous 1,434,169 26.51%
Holding current value
$49.3 Million
Previous $78.6 Million 29.6%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.38 - $54.59 $16.5 Million - $20.8 Million
-380,131 Reduced 26.51%
1,054,038 $55.3 Million
Q2 2024

Aug 14, 2024

SELL
$51.76 - $64.15 $2.46 Million - $3.05 Million
-47,560 Reduced 3.21%
1,434,169 $78.6 Million
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $10.3 Million - $12.2 Million
212,857 Added 16.78%
1,481,729 $82.9 Million
Q4 2023

Feb 14, 2024

BUY
$43.45 - $53.66 $15.3 Million - $18.9 Million
352,240 Added 38.43%
1,268,872 $65.7 Million
Q3 2023

Nov 14, 2023

BUY
$50.12 - $58.87 $22.5 Million - $26.4 Million
449,136 Added 96.07%
916,632 $48.5 Million
Q2 2023

Aug 14, 2023

BUY
$42.28 - $51.43 $8.23 Million - $10 Million
194,566 Added 71.29%
467,496 $24 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $2.48 Million - $3.53 Million
60,746 Added 28.63%
272,930 $11.9 Million
Q4 2022

Feb 14, 2023

SELL
$43.88 - $56.16 $101,801 - $130,291
-2,320 Reduced 1.08%
212,184 $11.8 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $35,164 - $48,345
-727 Reduced 0.34%
214,504 $10.9 Million
Q2 2022

Aug 15, 2022

BUY
$57.25 - $86.63 $12,938 - $19,578
226 Added 0.11%
215,231 $13.4 Million
Q1 2022

May 16, 2022

SELL
$71.02 - $86.99 $187,989 - $230,262
-2,647 Reduced 1.22%
215,005 $17.6 Million
Q4 2021

Feb 14, 2022

SELL
$76.72 - $92.68 $38,436 - $46,432
-501 Reduced 0.23%
217,652 $19 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $131,362 - $153,135
1,728 Added 0.8%
218,153 $17.3 Million
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $888,697 - $1.05 Million
-12,101 Reduced 5.3%
216,425 $18.2 Million
Q1 2021

May 17, 2021

BUY
$62.9 - $82.41 $7.83 Million - $10.3 Million
124,456 Added 119.59%
228,526 $16.8 Million
Q4 2020

Feb 12, 2021

SELL
$46.01 - $68.74 $504,683 - $754,009
-10,969 Reduced 9.54%
104,070 $6.89 Million
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $167,933 - $231,644
-4,007 Reduced 3.37%
115,039 $5.2 Million
Q2 2020

Aug 14, 2020

SELL
$39.87 - $56.9 $255,048 - $363,989
-6,397 Reduced 5.1%
119,046 $5.73 Million
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $79,082 - $176,768
-2,311 Reduced 1.81%
125,443 $5.68 Million
Q4 2019

Feb 14, 2020

SELL
$68.92 - $85.27 $220,475 - $272,778
-3,199 Reduced 2.44%
127,754 $9.64 Million
Q3 2019

Nov 14, 2019

SELL
$71.74 - $86.35 $2.85 Million - $3.43 Million
-39,665 Reduced 23.25%
130,953 $9.66 Million
Q2 2019

Aug 14, 2019

BUY
$66.45 - $97.36 $1.17 Million - $1.71 Million
17,556 Added 11.47%
170,618 $12.3 Million
Q1 2019

May 15, 2019

SELL
$86.15 - $100.49 $20.4 Million - $23.8 Million
-236,939 Reduced 60.75%
153,062 $14.9 Million
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $56.1 Million - $83.6 Million
-666,396 Reduced 63.08%
390,001 $35.7 Million
Q3 2018

Nov 14, 2018

BUY
$101.02 - $130.95 $47.7 Million - $61.8 Million
471,957 Added 80.75%
1,056,397 $131 Million
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $9 Million - $11.6 Million
110,066 Added 23.2%
584,440 $58.3 Million
Q1 2018

May 15, 2018

BUY
$79.95 - $89.74 $27.3 Million - $30.6 Million
341,036 Added 255.77%
474,374 $42 Million
Q4 2017

Feb 12, 2018

SELL
$71.8 - $88.21 $790,661 - $971,368
-11,012 Reduced 7.63%
133,338 $10.7 Million
Q3 2017

Nov 07, 2017

BUY
$60.32 - $70.06 $8.71 Million - $10.1 Million
144,350
144,350 $10.1 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.